Industry Symposium by Bayer & Siemens Healthineers
SY 05 - Diagnosing the under-diagnosed: Identifying CTEPH in the COVID-19 era
Lectures
1
SY05 - Industry Symposium by Bayer & Siemens Healthineers: Diagnosing the under-diagnosed: Identifying CTEPH in the COVID-19 era
69:05Siemens and Bayer
This session is available free of charge. To watch this session please login with your ESR MyUserArea credentials or create a new account after clicking the login button in the upper right corner.
Once you can see the session under 'My Courses' your registration was successful.
|
SY 05-1
5 min
|
Welcome and Introduction
Deepa Gopalan, London / UK
|
|
SY 05-2
15 min
|
From PE to CTEPH and the impact of COVID-19
Erik Klok, Leiden / Netherlands
|
|
Introduce and explore the association between acute PE and CTEPH, and consider any effects that COVID-19 has had on this
|
|
|
SY 05-3
15 min
|
Identifying and discovering signs of CTEPH
Deepa Gopalan, London / UK
|
|
Summarize the strengths and limitations of the core imaging modalities used to identify CTEPH, and describe the key signs of CTEPH on computed tomography pulmonary angiography (CTPA), including important new developments in this field
|
|
|
SY 05-4
15 min
|
What does the future hold for CTEPH imaging?
Martine Rémy-Jardin, Lille / France
|
|
Describe the roles that Dual Energy Computed Tomography (DECT) and machine learning can play in the diagnosis of CTEPH, now and in the future
|
|
|
10 min
|
Q&A and close
|